837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro

• Malin Lindstedt,
• Peter Ellmark,
• Karin Hägerbrand,
• Sara Fritzell,
• Anette Sundstedt,
• David Gomez Jimenez,
• Anneli Nilsson,
• Lill Ljung,
• Mattias Levin,
• Mona Celander,
• Ida Uddbäck,
• Amulya Krishna Shetty,
• Hampus Andersson

Affiliations

Malin Lindstedt

1Alligator Bioscience AB, Lund, Sweden

Peter Ellmark

1Alligator Bioscience AB, Lund, Sweden

Karin Hägerbrand

1Alligator Bioscience AB, Lund, Sweden

Sara Fritzell

1Alligator Bioscience AB, Lund, Sweden

Anette Sundstedt

1Alligator Bioscience AB, Lund, Sweden

David Gomez Jimenez

1Alligator Bioscience AB, Lund, Sweden

Anneli Nilsson

1Alligator Bioscience AB, Lund, Sweden

Lill Ljung

1Alligator Bioscience AB, Lund, Sweden

Mattias Levin

1Alligator Bioscience AB, Lund, Sweden

Mona Celander

1Alligator Bioscience AB, Lund, Sweden

Ida Uddbäck

1Alligator Bioscience AB, Lund, Sweden

Amulya Krishna Shetty

1Alligator Bioscience AB, Lund, Sweden

Hampus Andersson

1Alligator Bioscience AB, Lund, Sweden